AbbVie (NYSE:ABBV) is preparing to release its quarterly earnings on Friday, 2025-10-31. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect AbbVie to report an earnings per share (EPS) of $1.78.
AbbVie bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Earnings Track Record
Last quarter the company beat EPS by $0.07, which was followed by a 3.28% increase in the share price the next day.
Here's a look at AbbVie's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | 2.90 | 2.38 | 2.26 | 2.92 |
| EPS Actual | 2.97 | 2.46 | 2.16 | 3.00 |
| Price Change % | 3.00 | 3.00 | 5.00 | 1.00 |
AbbVie Share Price Analysis
Shares of AbbVie were trading at $225.14 as of October 29. Over the last 52-week period, shares are up 11.82%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for AbbVie visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
